"Clostridium Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infections with bacteria of the genus CLOSTRIDIUM.
| Descriptor ID |
D003015
|
| MeSH Number(s) |
C01.252.410.222
|
| Concept/Terms |
Clostridium Infections- Clostridium Infections
- Infections, Clostridium
- Clostridium Infection
- Infection, Clostridium
Clostridium difficile Infection- Clostridium difficile Infection
- Clostridium difficile Infections
- Infection, Clostridium difficile
- Infections, Clostridium difficile
Clostridium sordellii Infection- Clostridium sordellii Infection
- Clostridium sordellii Infections
- Infection, Clostridium sordellii
- Infections, Clostridium sordellii
Clostridium perfringens Infections- Clostridium perfringens Infections
- Clostridium perfringens Infection
- Infection, Clostridium perfringens
- Infections, Clostridium perfringens
|
Below are MeSH descriptors whose meaning is more general than "Clostridium Infections".
Below are MeSH descriptors whose meaning is more specific than "Clostridium Infections".
This graph shows the total number of publications written about "Clostridium Infections" by people in this website by year, and whether "Clostridium Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 1 | 1 |
| 1994 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2009 | 2 | 0 | 2 |
| 2010 | 3 | 0 | 3 |
| 2012 | 1 | 0 | 1 |
| 2013 | 3 | 0 | 3 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 4 | 1 | 5 |
| 2018 | 3 | 1 | 4 |
| 2019 | 0 | 1 | 1 |
| 2020 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Clostridium Infections" by people in Profiles.
-
Pope RL, Chitrakar A, Sah P, Shadid T, Ballard JD, Zenewicz LA. Clostridioides difficile Toxin B Activates Group 3 Innate Lymphocytes. Infect Immun. 2022 04 21; 90(4):e0007322.
-
Lang GA, Norman K, Amadou Amani S, Shadid TM, Ballard JD, Lang ML. Use of a Clostridioides difficile Murine Immunization and Challenge Model to Evaluate Single and Combination Vaccine Adjuvants Consisting of Alum and NKT Cell-Activating Ligands. Front Immunol. 2021; 12:818734.
-
Bishop CE, Shadid TM, Lavey NP, Kempher ML, Ballard JD, Duerfeldt AS. Identification of ClpP Dual Isoform Disruption as an Antisporulation Strategy for Clostridioides difficile. J Bacteriol. 2022 02 15; 204(2):e0041121.
-
Amadou Amani S, Lang GA, Ballard JD, Lang ML. The Murine Neonatal Fc Receptor Is Required for Transport of Immunization-Induced C. difficile-Specific IgG to the Gut and Protection against Disease but Does Not Affect Disease Susceptibility. Infect Immun. 2021 09 16; 89(10):e0027421.
-
Lee P, Sinha AA, Soma VL, Cruz C, Wang T, Aroniadis O, Herold BC, Frenette PS, Goldman DL, Manwani D. Very low incidence of Clostridioides difficile infection in pediatric sickle cell disease patients. Haematologica. 2020 09 14; 106(5):1489-1490.
-
Shah HB, Smith K, Scott EJ, Larabee JL, James JA, Ballard JD, Lang ML. Human C. difficile toxin-specific memory B cell repertoires encode poorly neutralizing antibodies. JCI Insight. 2020 08 20; 5(16).
-
Amadou Amani S, Shadid T, Ballard JD, Lang ML. Clostridioides difficile Infection Induces an Inferior IgG Response to That Induced by Immunization and Is Associated with a Lack of T Follicular Helper Cell and Memory B Cell Expansion. Infect Immun. 2020 02 20; 88(3).
-
Frickenstein AN, Jones MA, Behkam B, McNally LR. Imaging Inflammation and Infection in the Gastrointestinal Tract. Int J Mol Sci. 2019 Dec 30; 21(1).
-
Gentry CA, Nguyen PK, Thind S, Kurdgelashvili G, Skrepnek GH, Williams RJ. Fidaxomicin versus oral vancomycin for severe Clostridium difficile infection: a retrospective cohort study. Clin Microbiol Infect. 2019 Aug; 25(8):987-993.
-
Tieu JD, Williams RJ, Skrepnek GH, Gentry CA. Clinical outcomes of fidaxomicin vs oral vancomycin in recurrent Clostridium difficile infection. J Clin Pharm Ther. 2019 Apr; 44(2):220-228.